ReviewCancers2026

Risk Stratification and Strategies Towards Front-Line Therapy of EGFR-Mutant NSCLC: A Narrative Review.

Kyle Taing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.